421
Views
0
CrossRef citations to date
0
Altmetric
Research Article

The cost associated with the development of the antimicrobial stewardship program in the adult general medicine setting in Qatar

ORCID Icon, , ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, , , , ORCID Icon & ORCID Icon show all

References

  • Abushanab, D., Gulied, A., Hamad, A., Abu-Tineh, M., Abdul Rouf, P. V., Al Hail, M., El-Kassem, W., El Hajj, M. S., & Al-Badriyeh, D. (2023). Cost savings and cost avoidance with the inpatient clinical pharmacist interventions in a tertiary cancer care hospital. Journal of Oncology Pharmacy Practice, 10781552231160276.
  • Al, M. J., van Hout, B. A., Michel, B. C., & Rutten, F. F. (1998). Sample size calculation in economic evaluations. Health Economics, 7(4), 327–335. https://doi.org/10.1002/(SICI)1099-1050(199806)7:4<327::AID-HEC342>3.0.CO;2-U
  • Aljayyousi, G. F., Abdel-Rahman, M. E., El-Heneidy, A., Kurdi, R., & Faisal, E. (2019). Public practices on antibiotic use: A cross-sectional study among Qatar University students and their family members. PLoS One, 14(11), e0225499. https://doi.org/10.1371/journal.pone.0225499
  • Apisarnthanarak, A., Danchaivijitr, S., Khawcharoenporn, T., Limsrivilai, J., Warachan, B., Bailey, T. C., & Fraser, V. J. (2006). Effectiveness of education and an antibiotic-control program in a tertiary care hospital in Thailand. Clinical Infectious Diseases, 42(6), 768–775. https://doi.org/10.1086/500325
  • Balasiu, A. D., & MacKenzie, C. R. (2023). Teicoplanin-Resistant coagulase-negative staphylococci: Do the current susceptibility testing methods reliably detect this elusive phenotype? Antibiot (Basel, Switzerland), 12.
  • Borde, J. P., Kaier, K., Steib-Bauert, M., Vach, W., Geibel-Zehender, A., Busch, H., Bertz, H., Hug, M., de With, K., & Kern, W. V. (2014). Feasibility and impact of an intensified antibiotic stewardship programme targeting cephalosporin and fluoroquinolone use in a tertiary care university medical center. BMC Infectious Diseases, 14(1), 201. https://doi.org/10.1186/1471-2334-14-201
  • Boyles, T. H., Whitelaw, A., Bamford, C., Moodley, M., Bonorchis, K., Morris, V., Rawoot, N., Naicker, V., Lusakiewicz, I., Black, J., Stead, D., Lesosky, M., Raubenheimer, P., Dlamini, S., & Mendelson, M. (2013). Antibiotic stewardship ward rounds and a dedicated prescription chart reduce antibiotic consumption and pharmacy costs without affecting inpatient mortality or re-admission rates. PLoS One, 8(12), e79747. https://doi.org/10.1371/journal.pone.0079747
  • Branham, A. R., Katz, A. J., Moose, J. S., Ferreri, S. P., Farley, J. F., & Marciniak, M. W. (2013). Retrospective analysis of estimated cost avoidance following pharmacist-provided medication therapy management services. Journal of Pharmacy Practice, 26(4), 420–427. https://doi.org/10.1177/0897190012465992
  • Bruno-Murtha, L. A., Brusch, J., Bor, D., Li, W., & Zucker, D. (2005). A pilot study of antibiotic cycling in the community hospital setting. Infection Control & Hospital Epidemiology, 26(1), 81–87. https://doi.org/10.1086/502491
  • Centers for Disease Control and Prevention CDC: 1 in 3 Antibiotic Prescriptions Unnecessary. (2022). Retrived December 12, 2022 from: https://www.cdc.gov/media/releases/2016/p0503-unnecessaryprescriptions.html.
  • Charlson, M. E., Pompei, P., Ales, K. L., & MacKenzie, C. R. (1987). A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. Journal of Chronic Diseases, 40(5), 373–383. https://doi.org/10.1016/0021-9681(87)90171-8
  • Chen, C.-C., Hsiao, F.-Y., Shen, L.-J., & Wu, C.-C. (2017). The cost-saving effect and prevention of medication errors by clinical pharmacist intervention in a nephrology unit. Medicine, 96(34), e7883. https://doi.org/10.1097/MD.0000000000007883
  • Classen, D. C., Pestotnik, S. L., Evans, R. S., Lloyd, J. F., & Burke, J. P. (1997). Adverse drug events in hospitalized patients. Excess length of stay,: extra costs, and attributable mortality. JAMA: The Journal of the American Medical Association, 277(4), 301–306. https://doi.org/10.1001/jama.1997.03540280039031
  • Coast, J., Smith, R. D., & Millar, M. R. (1996). Superbugs: Should antimicrobial resistance be included as a cost in economic evaluation? Health Economics, 5(3), 217–226. https://doi.org/10.1002/(SICI)1099-1050(199605)5:3<217::AID-HEC200>3.0.CO;2-S
  • Cook, P. P., Catrou, P. G., Christie, J. D., Young, P. D., & Polk, R. E. (2004). Reduction in broad-spectrum antimicrobial use associated with no improvement in hospital antibiogram. Journal of Antimicrobial Chemotherapy, 53(5), 853–859. https://doi.org/10.1093/jac/dkh163
  • COVID-19 rapid guideline: Managing COVID-19. (2022). [Internet]. 2022. [cited 2022 Aug 14]. https://www.nice.org.uk/guidance/ng191/resources/covid19-rapid-guideline-managing-covid19-pdf-51035553326.
  • Davey, P., Marwick, C. A., Scott, C. L., Charani, E., McNeil, K., Brown, E., Gould, I. M., Ramsay, C. R., & Michie, S. (2017). Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database of Systematic Reviews, 2, CD003543. 10 .100214651858.CD003543.pub4
  • Dik, J.-W. H., Hendrix, R., Friedrich, A. W., Luttjeboer, J., Panday, P. N., Wilting, K. R., et al. (2015). Cost-minimization model of a multidisciplinary antibiotic stewardship team based on a successful implementation on a urology ward of an academic hospital. PLoS One, 10(e0126106), e0126106.
  • Gallagher, J., Byrne, S., Woods, N., Lynch, D., & McCarthy, S. (2014). Cost-outcome description of clinical pharmacist interventions in a university teaching hospital. BMC Health Services Research, 14(1), 177. https://doi.org/10.1186/1472-6963-14-177
  • Garcell, H. G., Arias, A. V., Fernandez, E. A., Guerrero, Y. B., & Serrano, R. N. A. (2016). Antibiotic consumption during a 4-year period in a community hospital with an antimicrobial stewardship program. Oman Medical Journal, 31(5), 352–356. https://doi.org/10.5001/omj.2016.70
  • Garcell, H. G., Arias, A. V., Sandoval, C. P., Valle Gamboa, M. E., Sado, A. B., & Alfonso Serrano, R. N. (2017). Impact of a focused antimicrobial stewardship program in adherence to antibiotic prophylaxis and antimicrobial consumption in appendectomies. Journal of Infection and Public Health, 10(4), 415–420. https://doi.org/10.1016/j.jiph.2016.06.006
  • Hagert, B. L., Williams, C., Wieser, C. M., Rohrich, M. A., Lo, T. S., Newman, W. P., & Koo, J. M. (2012). Implementation and outcome assessment of an inpatient antimicrobial stewardship program. Hospital Pharmacy, 47(12), 939–945. https://doi.org/10.1310/hpj4712-939
  • Hamad Medical Corporation. (2023). https://www.hamad.qa/EN/Pages/default.aspx (accessed on 9 July 2023).
  • Ho, B. P., Lau, T. T. Y., Balen, R. M., Naumann, T. L., & Jewesson, P. J. (2005). The impact of a pharmacist-managed dosage form conversion service on ciprofloxacin usage at a major Canadian teaching hospital: A pre- and post-intervention study. BMC Health Services Research, 5(1), 48. https://doi.org/10.1186/1472-6963-5-48
  • Hohn, A., Heising, B., Hertel, S., Baumgarten, G., Hochreiter, M., & Schroeder, S. (2015). Antibiotic consumption after implementation of a procalcitonin-guided antimicrobial stewardship programme in surgical patients admitted to an intensive care unit: A retrospective before-and-after analysis. Infection, 43(4), 405–412. https://doi.org/10.1007/s15010-014-0718-x
  • Holmes, A. H., Moore, L. S. P., Sundsfjord, A., Steinbakk, M., Regmi, S., Karkey, A., Guerin, P. J., & Piddock, L. J. V. (2016). Understanding the mechanisms and drivers of antimicrobial resistance. Lancet (London, England), 387, 176–187. https://doi.org/10.1016/S0140-6736(15)00473-0
  • Hoyer, E. H., Brotman, D. J., Apfel, A., Leung, C., Boonyasai, R. T., Richardson, M., Lepley, D., & Deutschendorf, A. (2018). Improving outcomes after hospitalization: A prospective observational multicenter evaluation of care coordination strategies for reducing 30-day readmissions to Maryland hospitals. Journal of General Internal Medicine, 33(5), 621–627. https://doi.org/10.1007/s11606-017-4218-4
  • Hübner, C., & Flessa, S. (2016). Reimbursement for hospital-acquired infections with multidrug resistant organisms in German DRG system. Economics & Sociology, 9(3), 111e–1118. https://doi.org/10.14254/2071-789X.2016/9-3/10
  • Hübner, C., Hübner, N.-O., Hopert, K., Maletzki, S., & Flessa, S. (2014). Analysis of MRSA-attributed costs of hospitalized patients in Germany. European Journal of Clinical Microbiology & Infectious Diseases, 33(10), 1817–1822. https://doi.org/10.1007/s10096-014-2131-x
  • Huebner, C., Flessa, S., & Huebner, N.-O. (2019). The economic impact of antimicrobial stewardship programmes in hospitals: A systematic literature review. Journal of Hospital Infection, 102(4), 369–376. https://doi.org/10.1016/j.jhin.2019.03.002
  • Hurst, A. L., Child, J., Pearce, K., Palmer, C., Todd, J. K., & Parker, S. K. (2016). Handshake stewardship: A highly effective rounding-based antimicrobial optimization service. Pediatric Infectious Disease Journal, 35(10), 1104–1110. https://doi.org/10.1097/INF.0000000000001245
  • Hwang, S., & Kwon, K. T. (2021). Core elements for successful implementation of antimicrobial stewardship programs. Infection & Chemotherapy, 53(3), 421–435. https://doi.org/10.3947/ic.2021.0093
  • Johnson, S., Lavergne, V., Skinner, A. M., Gonzales-Luna, A. J., Garey, K. W., Kelly, C. P., & Wilcox, M. H. (2021). Clinical practice guideline by the Infectious Diseases Society of America (IDSA) and society for healthcare epidemiology of America (SHEA): 2021 focused update guidelines on management of clostridioides difficile infection in adults. Clinical Infectious Diseases, 73(5), e1029–e1044. https://doi.org/10.1093/cid/ciab549
  • Krivoy, N., El-Ahal, W. A., Bar-Lavie, Y., & Haddad, S. (2007). Antibiotic prescription and cost patterns in a general intensive care unit. Pharmacy Practice (Internet), 5(2), 67–73. https://doi.org/10.4321/S1886-36552007000200003
  • Lee, T. C., Frenette, C., Jayaraman, D., Green, L., & Pilote, L. (2014). Antibiotic self-stewardship: Trainee-led structured antibiotic time-outs to improve antimicrobial use. Annals of Internal Medicine, 161(1), S53–S58. https://doi.org/10.7326/M14-0820
  • Liew, Y. X., Lee, W., Kwa, A. L.-H., & Chlebicki, M. P. (2015). Cost effectiveness of an antimicrobial stewardship programme. International Journal of Antimicrobial Agents, 594–595. https://doi.org/10.1016/j.ijantimicag.2015.08.008
  • Lin, Y.-S., Lin, I.-F., Yen, Y.-F., Lin, P.-C., Shiu, Y.-C., Hu, H.-Y., & Yang, Y.-P. (2013). Impact of an antimicrobial stewardship program with multidisciplinary cooperation in a community public teaching hospital in Taiwan. American Journal of Infection Control, 41(11), 1069–1072. https://doi.org/10.1016/j.ajic.2013.04.004
  • Mach, R., Vlcek, J., Prusova, M., Batka, P., Rysavy, V., & Kubena, A. (2007). Impact of a multidisciplinary approach on antibiotic consumption,: cost and microbial resistance in a Czech hospital. Pharmacy World & Science, 29(5), 565–572. https://doi.org/10.1007/s11096-006-9059-x
  • MacVane, S. H., & Nolte, F. S. (2016). Benefits of adding a rapid PCR-based blood culture identification panel to an established antimicrobial stewardship program. Journal of Clinical Microbiology, 54(10), 2455–2463. https://doi.org/10.1128/JCM.00996-16
  • Madaras-Kelly, K. J., Remington, R. E., Lewis, P. G., & Stevens, D. L. (2006). Evaluation of an intervention designed to decrease the rate of nosocomial methicillin-resistant staphylococcus aureus infection by encouraging decreased fluoroquinolone use. Infection Control & Hospital Epidemiology, 27(2), 155–169. https://doi.org/10.1086/500060
  • Malani, A. N., Richards, P. G., Kapila, S., Otto, M. H., Czerwinski, J., & Singal, B. (2013). Clinical and economic outcomes from a community hospital’s antimicrobial stewardship program. American Journal of Infection Control, 41(2), 145–148. https://doi.org/10.1016/j.ajic.2012.02.021
  • Martínez, M. J., Freire, A., Castro, I., Inaraja, M. T., Ortega, A., Del Campo, V., Rodriguez, I., Bardán, B., Morano, L. E., & Garcia, J. F. (2000). Clinical and economic impact of a pharmacist-intervention to promote sequential intravenous to oral clindamycin conversion. Pharmacy World and Science, 22(2), 53–58. https://doi.org/10.1023/A:1008769204178
  • Ministry of Public Health. (2019). Qatar National Health Strategy 2018–2022. https://www.moph.gov.qa/HSF/Documents/short%20report%20eng%2020.03.2018.pdf/ (13 February 2020,: date last accessed).
  • Miyamoto, G. C., Ben, ÂJ, Bosmans, J. E., van Tulder, M. W., Lin, C.-W. C., Cabral, C. M. N., & van Dongen, J. M. (2021). Interpretation of trial-based economic evaluations of musculoskeletal physical therapy interventions. Brazilian Journal of Physical Therapy, 25(5), 514–529. https://doi.org/10.1016/j.bjpt.2021.06.011
  • Miyawaki, K., Miwa, Y., Tomono, K., & Kurokawa, N. (2010). Impact of antimicrobial stewardship by infection control team in a Japanese teaching hospital. Yakugaku Zasshi, 130(8), 1105–1111. https://doi.org/10.1248/yakushi.130.1105
  • Nasr, Z. G., Jibril, F., Elmekaty, E., Sonallah, H., Chahine, E. B., & AlNajjar, A. (2021). Assessment of antimicrobial stewardship programs within governmental hospitals in Qatar: A SWOC analysis. International Journal of Pharmacy Practice, 29(1), 70–77. https://doi.org/10.1093/ijpp/riaa011
  • Nathwani, D., Varghese, D., Stephens, J., Ansari, W., Martin, S., & Charbonneau, C. (2019). Value of hospital antimicrobial stewardship programs [ASPs]: a systematic review. Antimicrobial Resistance And Infection Control, 8(35), 35.
  • Ng, C. K., Wu, T. C., Chan, W. M. J., Leung, Y. S. W., Li, C. K. P., Tsang, D. N. C., & Leung, G. M. (2008). Clinical and economic impact of an antibiotics stewardship programme in a regional hospital in Hong Kong. Quality and Safety in Health Care, 17(5), 387–392. https://doi.org/10.1136/qshc.2007.023267
  • Nilholm, H., Holmstrand, L., Ahl, J., Månsson, F., Odenholt, I., Tham, J., Melander, E., & Resman, F. (2015). An audit-based, infectious disease specialist-guided antimicrobial stewardship program profoundly reduced antibiotic use without negatively affecting patient outcomes. Open Forum Infectious Diseases, 2(2), ofv042. https://doi.org/10.1093/ofid/ofv042
  • Nowak, M. A., Nelson, R. E., Breidenbach, J. L., Thompson, P. A., & Carson, P. J. (2012). Clinical and economic outcomes of a prospective antimicrobial stewardship program. American Journal of Health-System Pharmacy, 69, 1500–1508.
  • Obolski, U., Stein, G. Y., & Hadany, L. (2015). Antibiotic restriction might facilitate the emergence of multi-drug resistance. PLOS Computational Biology, 11(6), e1004340. https://doi.org/10.1371/journal.pcbi.1004340
  • Ojeniran, M., Shouval, R., Miskin, I. N., Moses, A. E., & Shmueli, A. (2010). Costs of appropriate and inappropriate use of antibiotics in the emergency department. The Israel Medical Association Journal, 12, 742–746.
  • Oosterheert, J. J., van Loon, A. M., Schuurman, R., Hoepelman, A. I. M., Hak, E., Thijsen, S., Nossent, G., Schneider, M. M. E., Hustinx, W. M. N., & Bonten, M. J. M. (2005). Impact of rapid detection of viral and atypical bacterial pathogens by real-time polymerase chain reaction for patients with lower respiratory tract infection. Clinical Infectious Diseases, 41(10), 1438–1444. https://doi.org/10.1086/497134
  • Organisation for Economic Co-operation and Development. (2016). Antimicrobial resistance - Policy insights.
  • Palmay, L., Elligsen, M., Walker, S. A. N., Pinto, R., Walker, S., Einarson, T., Simor, A., Rachlis, A., Mubareka, S., & Daneman, N. (2014). Hospital-wide rollout of antimicrobial stewardship: A stepped-wedge randomized trial. Clinical Infectious Diseases, 59(6), 867–874. https://doi.org/10.1093/cid/ciu445
  • Pate, P. G., Storey, D. F., & Baum, D. L. (2012). Implementation of an antimicrobial stewardship program at a 60-bed long-term acute care hospital. Infection Control & Hospital Epidemiology, 33(4), 405–408. https://doi.org/10.1086/664760
  • Pogue, J. M., Kaye, K. S., Cohen, D. A., & Marchaim, D. (2015). Appropriate antimicrobial therapy in the era of multidrug-resistant human pathogens. Clinical Microbiology and Infection, 21, 302–312.
  • Rohde, A. M., Zweigner, J., Wiese-Posselt, M., Schwab, F., Behnke, M., Kola, A., Obermann, B., Knobloch, J. K.-M., Feihl, S., Querbach, C., Gebhardt, F., Mischnik, A., Ihle, V., Schröder, W., Armean, S., Peter, S., Tacconelli, E., Hamprecht, A., Seifert, H., … Wolke, S. (2018). Incidence of infections due to third generation cephalosporin-resistant Enterobacteriaceae - a prospective multicentre cohort study in six German university hospitals. Antimicrobial Resistance & Infection Control, 7(1), 159. https://doi.org/10.1186/s13756-018-0452-8
  • Roth, G. A., Johnson, C., Abajobir, A., Abd-Allah, F., Abera, S. F., Abyu, G., et al. (2017). Global, regional, and national burden of cardiovascular diseases for 10 causes, 1990 to 2015. Journal of the American College of Cardiology, 70(1), 1–25. https://doi.org/10.1016/j.jacc.2017.04.052
  • Schuts, E. C., Hulscher, M. E. J. L., Mouton, J. W., Verduin, C. M., Stuart, J. W. T. C., Overdiek, H. W. P. M., van der Linden, P. D., Natsch, S., Hertogh, C. M. P. M., Wolfs, T. F. W., Schouten, J. A., Kullberg, B. J., & Prins, J. M. (2016). Current evidence on hospital antimicrobial stewardship objectives: A systematic review and meta-analysis. The Lancet Infectious Diseases, 16(7), 847–856. https://doi.org/10.1016/S1473-3099(16)00065-7
  • Sebaaly, J., Parsons, L. B., Pilch, N. A. W., Bullington, W., Hayes, G. L., & Easterling, H. (2015). Clinical and financial impact of pharmacist involvement in discharge medication reconciliation at an academic medical center: A prospective pilot study. Hospital Pharmacy, 50(6), 505–513. https://doi.org/10.1310/hpj5006-505
  • Smith, T., Philmon, C. L., Johnson, G. D., Ward, W. S., Rivers, L. L., Williamson, S. A., & Goodman, E. L. (2014). Antimicrobial stewardship in a community hospital: Attacking the more difficult problems. Hospital Pharmacy, 49(9), 839–846. https://doi.org/10.1310/hpj4909-839
  • Standiford, H. C., Chan, S., Tripoli, M., Weekes, E., & Forrest, G. N. (2012). Antimicrobial stewardship at a large tertiary care academic medical center: Cost analysis before: During, and after a 7-year program. Infection Control & Hospital Epidemiology, 33(4), 338–345. https://doi.org/10.1086/664909
  • Taggart, L. R., Leung, E., Muller, M. P., Matukas, L. M., & Daneman, N. (2015). Differential outcome of an antimicrobial stewardship audit and feedback program in two intensive care units: A controlled interrupted time series study. BMC Infectious Diseases, 15(1), 480. https://doi.org/10.1186/s12879-015-1223-2
  • Tomczyk, S., Zanichelli, V., Grayson, M. L., Twyman, A., Abbas, M., Pires, D., Allegranzi, B., & Harbarth, S. (2019). Control of carbapenem-resistant enterobacteriaceae, acinetobacter baumannii, and pseudomonas aeruginosa in healthcare facilities: A systematic review and reanalysis of quasi-experimental studies. Clinical Infectious Diseases, 68(5), 873–884. https://doi.org/10.1093/cid/ciy752
  • Weiss, A. J., & Elixhauser, A. (2006). Characteristics of adverse drug events originating during the hospital stay, 2011.
  • Wenzler, E., Goff, D. A., Mangino, J. E., Reed, E. E., Wehr, A., & Bauer, K. A. (2016). Impact of rapid identification of Acinetobacter Baumannii via matrix-assisted laser desorption ionization time-of-flight mass spectrometry combined with antimicrobial stewardship in patients with pneumonia and/or bacteremia. Diagnostic Microbiology and Infectious Disease, 84(1), 63–68. https://doi.org/10.1016/j.diagmicrobio.2015.09.018
  • World Health Organization. (2023). The ATC/DDD Methodology. https://www.who.int/tools/atc-ddd-toolkit/methodology (accessed on 9 July 2023).
  • Yu, K., Rho, J., Morcos, M., Nomura, J., Kaplan, D., Sakamoto, K., Bui, D., Yoo, S., & Jones, J. (2014). Evaluation of dedicated infectious diseases pharmacists on antimicrobial stewardship teams. American Journal of Health-System Pharmacy, 71, 1019–1028. https://doi.org/10.2146/ajhp130612